The global interventional cardiology and peripheral vascular devices market was valued at $8.7 billion in 2011 and is expected to grow to $12.7 billion by 2016. The market consists of devices used in coronary and peripheral endovascular procedures. Major drivers of growth include increasing demand for minimally invasive treatments and rising rates of coronary and peripheral artery diseases. North America currently dominates the market but Asia is growing the fastest.
Russian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls Jaipur
Global Interventional Cardiology Devices Market Report
1. Interventional Cardiology & Peripheral Vascular Devices Market To 2016 -
Global Trends & Competitive Analysis
The global interventional cardiology & peripheral vascular devices market consist of devices used
in both coronary and peripheral endovascular procedures which include Embolic Protection,
Chronic Total Occlusion, Coronary Atherectomy, Thrombectomy Devices, IVUS & Angiography
Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessory Devices. This market was
valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by
2016..
Buy Your Copy of Report: http://www.reportsnreports.com/reports/181599-interventional-
cardiology-peripheral-vascular-devices-market-to-2016-global-trends-competitive-analysis.html
Report Details:
Published: July 2012
Price Single User License: US $ 4650 Price Corporate User License: US $ 7150
The major driving factor for these markets would be the increasing demand for minimally invasive
percutaneous endovascular treatment. As the incidence cases of coronary and peripheral artery
diseases continue to rise in the coming years along with increasing trends in co-morbid conditions
such as obesity and diabetes, the vascular interventional devices market for treating these diseases
would show significant growth in the forecast period. The principal advantage of minimally
invasive endovascular procedures over surgery is short recovery time, short length scars, low risk
of infection, bleeding, and shorter hospital stays.
The stents used in interventional procedures represent the largest segment of the market. In the
global stents market, drug-eluting stents contributed the largest share. The key driving factor for
drug-eluting stents would be the increased usage of these stents, as restenosis complications are
considerably reduced by these stents compared to bare metal stents as well as DES show less long-
term problems after placement.
North America will be the biggest market for vascular interventional devices, followed by Europe.
However, Asian countries represent the fastest growing markets, as low procedural and
infrastructural costs have led to an increased drive of patients from developed regions towards
Asian countries such as India and China. Moreover, established players in the market such as
2. Abbott Vascular (U.S.), Boston cientific (U.S.) and Medtronic, Inc. (U.S.) have shown an increased
inclination towards Asian countries for market expansion.
Major players in the market include Abbott Vascular, Boston Scientific, Medtronic, Inc., C.R. Bard,
Inc. (U.S.), B Braun, Inc. (Germany), Cook Medical (U.S.), Cordis Corp. (U.S.), St. Jude Medical (U.S.),
Teleflex Medical (U.S.), Terumo Interventional Systems, Inc. (Japan), Bayer, Edward Lifesciences,
Covidien (Ireland), Endologix (U.S.), W.L.Gore & Associates Ltd. (U.S.), Volcano Corporation (U.S.),
and Angioscore Ltd. (U.S.) among others.
Scope of the Report
This research report categorizes the market for vascular interventional devices in coronary and
peripheral procedures into the following segments:
Angioplasty Procedures – Plain old balloon angioplasty (POBA), Percutaneous transluminal
coronary angioplasty (PTCA) and Percutaneous transluminal angioplasty (PTA)
The various devices used in angioplasty procedures are categorized into:
Angioplasty Balloons – Old/normal balloons, cutting balloons, scoring balloons and drug-eluting
balloons
Angioplasty Stents – Bare metal stents (BMS), drug-eluting stents (DES) and bioabsorbable stents
(BAS)
Catheters – Angiography catheters, guiding catheters, intravascular ultrasound (IVUS) catheters
and optical coherence tomography (OCT) catheters
Endovascular aortic repair (EVAR) stent grafts – Abdominal Aortic Aneurysm (AAA) stent grafts
and Thoracic Aortic Aneurysm (TAA) stent grafts
Inferior vena cava (IVC) filters – Permanent IVC filters and retrievable IVC filters
Plaque modification devices – Atherectomy devices and thrombectomy devices
Hemodynamic flow alteration devices – embolic protection devices (EPDs) and chronic total
occlusion (CTO) devices
Accessory devices – Guide wires, balloon inflation devices, introducer sheaths and vascular closure
devices (VCDs)
3. This interventional cardiology & peripheral vascular devices report forecasts the size of the market
over a period of five years (2011-2016). It also discusses the key market drivers, restraints and
opportunities of the market and its sub markets. The report’s ‘Strategy’ section sketches the
competitive landscape, featuring about 35 company profiles.
Table Of Contents
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 Increasing Demand for Minimally Invasive Treatment
3.2.1.2 Increasing Incidence of Coronary Artery Disease
3.2.1.3 Increasing Prevalence of Peripheral Vascular Disease
4. 3.2.1.4 Rapid Advancements in New Technologies
3.2.2 RESTRAINTS
3.2.2.1 Reimbursement Issues
3.2.2.2 Declining Average Selling Prices
3.2.2.3 Barrier to Entry
3.2.3 OPPORTUNITIES AND THREATS
3.2.4 TRENDS
3.3 MARKET SHARE ANALYSIS
4 ANGIOPLASTY PROCEDURES
4.1 INTRODUCTION
4.2 PLAIN OLD BALLOON ANGIOPLASTY (POBA)
4.3 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
4.4 PERCUTANEOUS TRANSLUMINAL (PERIPHERAL) ANGIOPLASTY (PTA)
5 ANGIOPLASTY BALLOONS
5.1 INTRODUCTION
5.2 BY BALLOON TYPE
5.2.1 OLD/NORMAL BALLOONS MARKET
5.2.2 CUTTING BALLOONS MARKET
5.2.3 SCORING BALLOONS MARKET
5.2.4 DRUG ELUTING BALLOONS MARKET
5.3 BY BALLOON PLATFORM
5.3.1 OVER-THE-WIRE BALLOON CATHETERS
5.3.2 RAPID EXCHANGE BALLOON CATHETERS
24. TABLE 149 ROW: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE, (EXCLUDING
BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 150 MERGERS & ACQUISITIONS, 2009 – 2012
TABLE 151 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 – 2012
TABLE 152 NEW PRODUCTS LAUNCH, 2009 – 2012
TABLE 153 APPROVALS, 2009 – 2012
TABLE 154 EXPANSIONS, 2009 –2012
TABLE 155 OTHER DEVELOPMENTS, 2009 – 2012
TABLE 156 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010
($MILLION)
TABLE 157 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 158 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 159 ASAHI INTECC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 160 ASAHI INTECC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 161 ASAHI INTECC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 162 BAYER AG: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 163 BAYER AG: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 164 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 165 BIOSENSORS INTERNATIONAL GROUP LTD: TOTAL REVENUE AND R&D EXPENSES,
2009 – 2011 ($MILLION)
TABLE 166 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011
($MILLION)
TABLE 167 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY GEOGRAPHY, 2009 –
2011 ($MILLION)
TABLE 168 BOSTON SCIENTIFIC : TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 169 BOSTON SCIENTIFIC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 170 BOSTON SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
25. TABLE 171 B. BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010
($MILLION)
TABLE 172 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 173 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010
($MILLION)
TABLE 174 COVIDIEN PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 175 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 176 COVIDIEN PLC : TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 177 C.R. BARD INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 178 C.R. BARD INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 179 C.R. BARD INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 180 EDWARDS: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 181 EDWARDS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 182 EDWARDS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 183 ENDOLOGIX INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 184 ENDOLOGIX INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 185 LOMBARD: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 186 LOMBARD: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 187 GETINGE AB : TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 188 GETINGE AB : TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 189 GETINGE AB: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2011 ($MILLION)
TABLE 190 MEDTRONIC INC: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 191 MEDTRONIC INC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 192 MEDTRONIC INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 193 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010
($MILLION)
26. TABLE 194 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010
($MILLION)
TABLE 195 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010
($MILLION)
TABLE 196 ST. JUDE MEDICAL INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010
($MILLION)
TABLE 197 ST. JUDE MEDICAL INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 198 ST. JUDE MEDICAL INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 199 TELEFLEX: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 200 TELEFLEX: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 201 TELEFLEX: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 202 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010
($MILLION)
TABLE 203 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 204 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 205 THE SPECTRANETICS CORPORATION: TOTAL REVENUE AND R&D EXPENSE, 2008 –
2010 ($MILLION)
TABLE 206 THE SPECTRANETICS CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010
($MILLION)
TABLE 207 THE SPECTRANETICS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010
($MILLION)
TABLE 208 VASCULAR SOLUTIONS: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010
($MILLION)
TABLE 209 VASCULAR SOLUTIONS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 210 VASCULAR SOLUTIONS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 211 VOLCANO CORPORATION: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010
($MILLION)
TABLE 212 VOLCANO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
27. TABLE 213 VOLCANO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010
($MILLION)
List Of Figures
FIGURE 1 GLOBAL ANGIOPLASTY PROCEDURES, BY SEGMENTS (2009-2016)
FIGURE 2 GEOGRAPHIC RANKING OF TOTAL STENTS MARKET
FIGURE 3 MARKET SEGMENTATION
FIGURE 4 MARKET DYNAMICS
FIGURE 5 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2010
FIGURE 6 ANGIOPLASTY PROCEDURES SEGMENTATION
FIGURE 7 ANGIOPLASTY BALLOONS SEGMENTATION
FIGURE 8 ANGIOPLASTY STENTS SEGMENTATION
FIGURE 9 CATHETERS MARKET SEGMENTATION
FIGURE 10 OPTICAL COHERENCE TOMOGRAPHY PROCESS
FIGURE 11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) SEGMENTATION
FIGURE 12 INFERIOR VENA CAVA FILTERS SEGMENTATION
FIGURE 13 PLAQUE MODIFICATION DEVICES SEGMENTATION
FIGURE 14 HEMODYNAMIC FLOW ALTERATION DEVICES SEGMENTATION
FIGURE 15 ACCESSORY DEVICES SEGMENTATION
FIGURE 16 KEY GROWTH STRATEGIES, JANUARY 2009 - FEBRUARY 2012
Browse more Research Reports @ http://www.reportsnreports.com/market-
research/medical-devices/
Contact Us:
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
28. Suite 800, Dallas 75252.
+ 1 888 391 5441
Email: sales@reportsandreports.com
Connect With Us: